TrueBlue, Inc. (TBI) - Q3 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 28, 2025. TrueBlue, Inc. is a leading provider of digitally-enabled workforce solutions operating through three reportable segments: PeopleReady (on-demand and skilled labor), PeopleManagement (contingent labor and outsourced workforce solutions), and PeopleSolutions (professional talent acquisition and RPO). The period includes the impact of the January 31, 2025, acquisition of Healthcare Staffing Professionals (HSP).
Key Financial Metrics
| Metric | Q3 2025 (13 Weeks) | Q3 2024 (13 Weeks) | YTD 2025 (39 Weeks) | YTD 2024 (39 Weeks) |
|---|---|---|---|---|
| Revenue | $431.3 million | $382.4 million | $1,197.8 million | $1,181.4 million |
| Gross Profit | $97.9 million | $100.0 million | $277.8 million | $303.8 million |
| Gross Margin | 22.7% | 26.2% | 23.2% | 25.7% |
| Operating Income (Loss) | $(0.1) million | $(6.9) million | $(17.2) million | $(82.4) million |
| Net Income (Loss) | $(1.9) million | $(7.6) million | $(16.4) million | $(114.0) million |
| Diluted EPS | $(0.06) | $(0.26) | $(0.55) | $(3.75) |
| Cash & Equivalents | $19.9 million | $22.5 million (Dec 2024) | N/A | |
| Long-Term Debt | $68.2 million | $7.6 million (Dec 2024) | ||
| Total Liquidity | $95.0 million | Includes $75.2M available under credit facility |
Material Changes vs. Prior Period
- Revenue Growth: Q3 revenue increased 12.8% year-over-year, driven by strong demand in skilled businesses (energy, commercial driving) and the HSP acquisition. YTD revenue grew 1.4%.
- Margin Compression: Gross margin declined 350 basis points in Q3 to 22.7%. This was primarily due to a shift in revenue mix toward lower-margin staffing businesses and less favorable workers' compensation reserve adjustments compared to the prior year.
- Cost Management: SG&A expenses decreased 8.2% in Q3 to $91.7 million, reflecting operational cost management actions and a leaner cost structure.
- Debt Utilization: Long-term debt increased significantly from $7.6 million to $68.2 million. The company drew $60.6 million on its Revolving Credit Facility during the period to fund the HSP acquisition and support working capital needs.
- Impairment Charges: A non-cash impairment charge of $0.2 million was recorded for an indefinite-lived trademark in the PeopleManagement segment. This contrasts with a $59.7 million goodwill impairment charge in the same period of the prior year.
Guidance, Outlook, and Risks
- Q4 2025 Outlook:
- Revenue: Expected to grow between 4% and 10% year-over-year, including ~4% inorganic growth from HSP.
- Gross Margin: Anticipated to decline between 370 and 410 basis points year-over-year due to business mix and prior-year reserve adjustments not repeating.
- SG&A: Expected to range between $91 million and $95 million.
- Tax: Minimal income tax expense expected due to valuation allowances on deferred tax assets.
- Subsequent Event (Impairment Risk): Following the execution of a sublease for the Chicago support center in October 2025, management expects a material non-cash impairment charge in Q4 2025. The carrying value of the asset group is approximately $24 million.
- Capital Structure: A Shareholder Rights Agreement ("Poison Pill") was adopted in May 2025 to deter unsolicited takeover attempts, specifically following a rejected proposal from HireQuest, Inc.
- Liquidity: The company maintains a $255 million Revolving Credit Facility. As of period end, $75.2 million was available for borrowing after considering covenants.
Investor Verification Checklist
- Q4 Impairment Magnitude: Verify the final impairment charge amount related to the Chicago support center sublease, which is expected to be material.
- Workers' Compensation Reserves: Monitor the trend of workers' compensation costs and reserve adjustments, which significantly impacted gross margins in Q3.
- Debt Covenants: Confirm continued compliance with the consolidated fixed charge coverage ratio (5.33) and asset coverage ratio (1.99) as debt levels remain elevated.
- HSP Integration: Assess the organic revenue contribution of the HSP acquisition versus the inorganic growth cited in guidance.
- Share Repurchases: Note that no shares were repurchased in Q3; verify if the $33.5 million remaining authorization will be utilized given the current liquidity position and debt levels.